Arch. Dis. Child

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Archives of Disease in Childhood - Fetal and Neonatal Edition 2006;91:F305-F307; doi:10.1136/adc.2005.076802
Copyright © 2006 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stephenson, T
Right arrow Articles by Budge, H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stephenson, T
Right arrow Articles by Budge, H

REVIEW

The future of neonatal therapeutic trials

T Stephenson, H Budge

Centre for Reproduction and Early Life, Academic Division of Child Health, School of Human Development, University of Nottingham, University Hospital, Nottingham, UK

Correspondence to:
Correspondence to:
Professor Stephenson
Centre for Reproduction and Early Life, Academic Division of Child Health, School of Human Development, University of Nottingham, E Floor, East Block, University Hospital, Nottingham NG7 2UH, UK; Terence.Stephenson{at}nottingham.ac.uk


ABSTRACT
Neonatology has undoubtedly benefited from clinical trials. Nevertheless, more treatments based on inadequate experimental evidence are given than those that are supported by a validated evidence base. Clinicians seeking the basis for their current and future clinical practice are faced with challenges in the shadow of recent UK legislation and government recommendations. All patients must be protected from inappropriate research, but the benefits of regulations must be appropriately balanced with those of properly conducted clinical trials. It is ethically difficult both to persist with treatments of unproven benefit and unknown harm and to deny infants potentially valuable therapies. It is important that trials are conducted within the new legislative framework, but their future may rest with innovative solutions and the determination of all involved in the process.


Keywords: therapeutic trials







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health